Cargando…

DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy

T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive malignant blood disorder with a high rate of relapse. Patients relapse as a result of minimal residual disease (MRD), which originates from residual T‐ALL cells in the bone marrow microenvironment (BMM). In the present study, it is observe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ruinan, Sun, Tao, Zhao, Xin, Li, Guosheng, Xia, Yuan, Zhou, Ying, Li, Wěi, Li, Wei, Ma, Daoxin, Ye, Jingjing, Ji, Min, Ji, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323667/ https://www.ncbi.nlm.nih.gov/pubmed/37072664 http://dx.doi.org/10.1002/advs.202205854

Ejemplares similares

DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy (Adv. Sci. 19/2023)
por: Jia, Ruinan, et al.
Publicado: (2023)

FZD7 regulates BMSCs-mediated protection of CML cells
por: Liu, Na, et al.
Publicado: (2015)

Preparation of hydroxyapatite coated porous carbon nanofibres for DEX loading and enhancing differentiation of BMSCs
por: Lan, Liujia, et al.
Publicado: (2023)

Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
por: Zou, Jie, et al.
Publicado: (2013)

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia
por: Zhou, Ying, et al.
Publicado: (2022)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

Tissue-specific changes in Srebf1 and Srebf2 expression and DNA methylation with perinatal phthalate exposure
por: Moody, Laura, et al.
Publicado: (2019)

PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway
por: Li, Banban, et al.
Publicado: (2021)

Efficiency of Cell Therapy to GC-Induced ONFH: BMSCs with Dkk-1 Interference Is Not Superior to Unmodified BMSCs
por: Zhun, Wei, et al.
Publicado: (2018)

SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population
por: Vargas-Alarcon, Gilberto, et al.
Publicado: (2019)

Regulatory Roles of SREBF1 and SREBF2 in Lipid Metabolism and Deposition in Two Chinese Representative Fat-Tailed Sheep Breeds
por: Liang, Chen, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells and γδT17 Cells Contribute to the Development of Gastric MALT Lymphoma in H. felis-Infected Mice
por: Zhao, Yanan, et al.
Publicado: (2020)

Adipocytes Provide Fatty Acids to Acute Lymphoblastic Leukemia Cells
por: Tucci, Jonathan, et al.
Publicado: (2021)

DEX, Delirium and Dilemma
por: Magoon, Rohan, et al.
Publicado: (2023)

SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease
por: Ivatt, Rachael M, et al.
Publicado: (2014)

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
por: Li, Wei, et al.
Publicado: (2018)

Downregulation of MiR-199b-5p Inducing Differentiation of Bone-Marrow Mesenchymal Stem Cells (BMSCs) Toward Cardiomyocyte-Like Cells via HSF1/HSP70 Pathway
por: Dai, Fangjie, et al.
Publicado: (2018)

Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene
por: Gründing, Anna Ricarda, et al.
Publicado: (2022)

Srebf1a is a key regulator of transcriptional control for adipogenesis
por: Ayala-Sumuano, Jorge-Tonatiuh, et al.
Publicado: (2011)

Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia
por: Feng, Panpan, et al.
Publicado: (2022)

Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac death
por: Fan, Yue-Mei, et al.
Publicado: (2008)

TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
por: Chen, Xintian, et al.
Publicado: (2023)

The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
por: Chen, Ping, et al.
Publicado: (2015)

Srebf1c preserves hematopoietic stem cell function and survival as a switch of mitochondrial metabolism
por: Lu, Yukai, et al.
Publicado: (2022)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020)

CREB-Regulated Transcriptional Coactivator 2 Proteome Landscape is Modulated by SREBF1
por: Lim, Jae Min, et al.
Publicado: (2023)

Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma
por: Lu, Ting, et al.
Publicado: (2016)

Injectable cartilaginous template transformed BMSCs into vascularized bone
por: Feng, Xiaoke, et al.
Publicado: (2018)

Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
por: Kruse, Aaron, et al.
Publicado: (2020)

Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer
por: Li, Li-Yan, et al.
Publicado: (2021)

Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) in Extending the Analgesic Duration of Pectoral Type I and II Blocks
por: Zusman, Robert P, et al.
Publicado: (2020)

Correction: Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020)

TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination
por: Ho, Wan Yun, et al.
Publicado: (2021)

Alternative regulatory mechanism for the maintenance of bone homeostasis via STAT5-mediated regulation of the differentiation of BMSCs into adipocytes
por: Seong, Semun, et al.
Publicado: (2021)

A procedure for Dex-induced gene transactivation in Arabidopsis ovules
por: Schubert, Jasmin, et al.
Publicado: (2022)

Measurable residual disease in childhood B-cell acute lymphoblastic leukemia
por: Gale, Robert Peter
Publicado: (2022)

Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance
por: Ji, Hongyan, et al.
Publicado: (2017)

Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®
por: Heninger, Anne-Kristin, et al.
Publicado: (2014)

Tumor Cell Survival Dependence on the DHX9 DExH-Box Helicase
por: Lee, Teresa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rmn1kamvk8rmqsv4gq2ji07do6